Termination by Bayer Sample Clauses
The 'Termination by Bayer' clause grants Bayer the explicit right to end the agreement under specified circumstances. Typically, this clause outlines the conditions under which Bayer may exercise this right, such as breach of contract by the other party, insolvency, or failure to meet certain milestones. By clearly defining Bayer's ability to terminate, the clause provides Bayer with flexibility and protection, ensuring it can exit the agreement if key obligations are not met or if continuing the relationship becomes untenable.
Termination by Bayer. Bayer shall have the right to terminate this Agreement in whole or on a Licensed Product-by-Licensed Product and country-by-country (except in any of the Major Market countries) basis at any time after the Effective Date on at least [[***]] days prior written notice to Atara.
Termination by Bayer. (a) Bayer shall have the right to terminate the Agreement [***] days’ prior written notice. If Bayer terminates the Agreement pursuant to this Section 18.2(a), Bayer shall pay to Nektar a termination fee equal to:
(i) [***], if such termination occurs [***]; or
(ii) [***], if such termination occurs [***]; or
(iii) [***], if such termination occurs [***]. Bayer shall pay such amount to Nektar in immediately available funds within [***] days after the effective date of such termination. The foregoing termination payment shall be in lieu of, and in substitution for, any reimbursement of costs, expenses or fees otherwise reimbursable (other than any Milestone Payments accrued but not yet paid) by Bayer to Nektar pursuant to this Agreement or any other payments with respect to activities relating to the Product under this Agreement (but only to the extent the obligation to make such payments has not accrued prior to the effective date of such termination).
(b) Bayer shall have the right to terminate the Agreement, at any time, upon [***] days’ prior written notice to Nektar in the event (i) of any development that causes the Product to fail to meet or to no longer meet the MACP that is outside of Bayer’s reasonable control, or (ii) that Bayer’s Global Pharmacovigilance Team (or any successor thereto within Bayer) determines that Development or Commercialization of the Product must be terminated because of safety issues outside of Bayer’s reasonable control (either of (i) or (ii), an “Unanticipated Development”). If Bayer terminates the Agreement for an Unanticipated Development, then Bayer and Nektar shall continue to bear their respective share of noncancellable costs and expenses becoming due after the effective date of such termination, to the extent such costs and expenses were set forth in a relevant Plan; provided that the Parties shall use reasonable efforts to minimize expenditures after the effective date of such termination. Upon request by Nektar, Bayer shall provide documentation to support its determination of the occurrence of an Unanticipated Development and meet with Nektar upon request to explain the basis for such determination.
Termination by Bayer. Bayer shall have the right to terminate this Agreement in its entirety upon two hundred seventy (270) days prior written notice.
Termination by Bayer. Notwithstanding anything contained herein to the contrary, Bayer shall have the right to terminate this Agreement, either in its entirety or in relation to any Collaboration Target and relevant Collaboration Compounds and Products under this Agreement, at any time for any or no reason in its sole discretion by giving sixty (60) days’ advance written notice to Arvinas.
Termination by Bayer